Radiotherapy (RT) is delivered for purposes of local control, but can also exert systemic
effect on remote and non-irradiated tumor deposits, which is called abscopal effect. The view …

Investigations into the interaction between radiotherapy and the host immune system have
uncovered new mechanisms that can potentially be exploited to improve the efficacy of …

Magnetic hyperthermia therapy (MHT) is noninvasive and features excellent tissue
penetration for deep-seated tumors, but unfortunately, it suffers the low therapeutic efficacy …

Radiotherapy (RT) is used routinely as a standard treatment for more than 50% of patients
with malignant tumors. The abscopal effect induced by local RT, which is considered as a …

Checkpoint blockade immunotherapy has received mainstream attention as a result of
striking and durable clinical responses in some patients with metastatic disease and a …

Radiotherapy is a major part in the treatment of most common cancers, but many patients
experience local recurrence with metastatic disease. In evaluating response biomarkers, we …

Considerable interest is being directed toward combining immune-checkpoint inhibition (ICI)
with radiotherapy to improve response rates to ICI, which have been disappointingly low at …

The therapeutic application of ionizing radiation has been largely based on its cytocidal
power combined with the ability to selectively target tumors. Radiotherapy effects on survival …

Immunotherapy, where the patient's own immune system is exploited to eliminate tumor
cells, has become one of the most prominent new cancer treatment options in the last …

Immune checkpoint inhibitors (ICIs) have recently revolutionized cancer treatment, providing
unprecedented clinical benefits. However, primary or acquired therapy resistance can affect …